Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 12/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 3/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.37 |
| ▸ | ESRRA | P11474 | 1/20 | 0.37 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.37 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3722006 | 0.91 | P2RX7 (0.40) | P2RX7EPHX2MAPK10MAPK8 | |
| SCHEMBL3719008 | 0.90 | P2RX7 (0.43) | P2RX7EPHX2MAPK10MAPK8ESRRA | |
| Trifluoroacetic Acid SCHEMBL3725905 | 0.87 | P2RX7 (0.41) | P2RX7EPHX2MAPK10MAPK8ESRRA | |
| SCHEMBL2549180 | 0.87 | L3MBTL1 (0.45) | P2RX7EPHX2PTPN7DUSP3 | |
| SCHEMBL3725821 | 0.84 | P2RX7 (0.40) | P2RX7EPHX2MAPK10MAPK8PTPN7 | |
| Trifluoroacetic Acid SCHEMBL2541472 | 0.83 | HDAC3 (0.43) | EPHX2PTPN7DUSP3 | |
| SCHEMBL3718987 | 0.82 | LIMK1 (0.37) | P2RX7MAPK10MAPK8ESRRA | |
| SCHEMBL13191699 | 0.82 | BDKRB1 (0.45) | P2RX7EPHX2 | |
| SCHEMBL3724229 | 0.82 | AR (0.39) | P2RX7EPHX2MAPK8ESRRA | |
| SCHEMBL13191711 | 0.81 | P2RX7 (0.37) | P2RX7EPHX2MAPK10MAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010097373-A1 | COMPOUNDS FOR USE AS BRADYKININ B1 ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-09-02 | — | — | WO | disclosed |